Eli Lilly and Co (NYSE:LLY)
| 230.21 Delayed Data As of 4:00pm ET |  -1.43 / -0.62%Today’s Change | 129.21 Today|||52-Week Range 275.87 | +36.35% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 231.64 |
| Today’s open | 232.22 |
| Day’s range | 229.78 - 233.69 |
| Volume | 2,158,894 |
| Average volume (3 months) | 3,069,037 |
| Market cap | $220.1B |
Data as of 4:00pm ET, 09/21/2021
Growth & Valuation
| Earnings growth (last year) | +36.99% |
| Earnings growth (this year) | -0.60% |
| Earnings growth (next 5 years) | +18.73% |
| Revenue growth (last year) | +9.95% |
| P/E ratio | 34.6 |
| Price/Sales | 6.28 |
| Price/Book | 39.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | -0.33 | -0.75% |
| ABBVAbbVie | +0.49 | +0.46% |
| NVSNovartis | +0.21 | +0.25% |
| MRKMerck | +0.01 | +0.01% |
Data as of 4:54pm ET, 09/21/2021
Financials
| Next reporting date | October 26, 2021 |
| EPS forecast (this quarter) | $1.96 |
| Annual revenue (last year) | $24.5B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 25.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
